First drug made with 3-D printer, for epilepsy, gets FDA nod

Aug 5, 2015

First drug made with 3-D printer, for epilepsy, gets FDA nod

The U.S. Food and Drug Administration said Tuesday it has approved the first drug made with a 3-D printer — pills for treating epilepsy. The Ohio-based company Aprecia Pharmaceuticals said its system can produce doses of up to 1,000 mg per tablet. It said ...

Mar 16, 2015

Studies boost hopes for new class of cholesterol medicines

New research boosts hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death and other heart-related problems. The U.S. government will decide this summer whether to allow two of these drugs on the market. People ...

Feb 4, 2015

Wine-tasting U.S. couple 'left toddlers in freezing car'

A couple allegedly left their two toddlers marooned in a car and strapped into their seats in near-freezing temperatures while attending a wine-tasting event in an upmarket Washington restaurant, U.S. police said. Jennie Chang, 46 — who works for the U.S. Food and Drug ...

Oct 30, 2014

FDA approves vaccine to block meningitis strain

Federal health regulators have approved the first vaccine to block a strain of bacteria that has caused sometimes deadly outbreaks of meningitis in college dormitories. The Food and Drug Administration said Wednesday it cleared Pfizer’s Trumenba to prevent a subtype of meningococcal disease in ...

Oct 14, 2014

Pfizer breast cancer drug to get FDA priority review

Pfizer said Monday an experimental breast cancer treatment will be given an accelerated review by U.S. regulators, speeding up the process for potential approval. The U.S. Food and Drug Administration has granted priority review for palbociclib, which would treat certain postmenopausal women with advanced ...

Artificial sweeteners seen boosting diabetes risk

Sep 18, 2014

Artificial sweeteners seen boosting diabetes risk

Promoted as an aid to good health, artificial sweeteners may in fact be boosting diabetes risk, said a study Wednesday that urged a rethink of their widespread use and endorsement. Also called noncalorific artificial sweeteners, or NAS, the additives are found in diet sodas, ...

Sep 12, 2014

FDA approves weight-loss drug Contrave

U.S. regulators are greenlighting a new weight-loss drug called Contrave, the third in a string of approvals for anti-obesity treatments. The drug was developed by Orexigen Therapeutics Inc., based in La Jolla, California. The Food and Drug Administration said Thursday that it is approved ...